FDA and DEA Opioid Crisis Defenses Under Fire: A Review

Proving the saying "opioid withdrawal won't kill you" WRONG!

Psychiatrists claim opioid withdrawal is harmless, despite research showing fatalities from withdrawal symptoms causing electrolyte imbalances which caused adrenaline toxicity, and lead to heart failure. The opioid crisis, involving the CDC and DEA, is fueled by flawed studies, lazy law enforcement, and misguided guidelines. Neuroscience advances addiction understanding, but poor research hinders progress. Recognizing addiction patterns and applying solutions combats the epidemic. Evidence points to profit over people, but change is possible by addressing root causes. DSM guidelines and federal protocols need revision, with accountability essential. The high mortality rate demands urgent action to bypass bureaucracy and find solutions.

5% mortality rate covered up in the Rapid Opioid Detoxification Study and the FDA Approved it!

They tried really hard to hide the fact that 1 out of 20 patients died during this Rapid Opioid Detoxification during General Anesthesia by Dr. Carl Gold and the FDA approved it even though 1 of 20 patients die. The Rapid Opioid Detoxification Study has a 5% mortality rate, yet the FDA approved it. The opioid crisis is a major concern, with agencies like the CDC and DEA crucial but often hindered. Neuroscience research advances understanding of addiction, but detox isn't simple. Fentanyl use leads to overdoses reversed by Narcan. Misguided guidelines fuel the crisis. Recognizing addiction patterns and applying solutions can combat opioid addiction. Evidence suggests a system prioritizing profits over people, but change is possible. Addressing root causes is key to tackling the opioid epidemic. DSM guidelines and federal protocols need revision, and accountability is essential. The mortality rate from opioid addiction demands urgent action to bypass bureaucracy and find solutions.

The Shocking Reason Germany Avoided America's Opioid Epidemic

Germany avoided America's opioid epidemic by focusing on replicable research studies, not lazy one non-reproducible study. Their approach emphasizes pattern recognition in health and neuroscience. While the US grapples with overdose deaths, Germany's success isn't due to inaction. Examining federal agents and Narcan shows a multi-faceted approach is needed to address opioid addiction myths. The 2nd law of thermodynamics can help understand addiction patterns. Understanding addiction neuroscience, including adrenaline's role, is crucial. An ombudsman informs the public about opioid dangers. By understanding opioid receptors and narcotics' brain impact, we can lower mortality rates. The key is recognizing addiction patterns and implementing effective solutions, not relying on single agents or bureaucracy.

PRESS RELEASE: A Discussion with FDA: Explaining millions of deaths

In this discussion with the FDA, we explore how their disregard for science has contributed to millions of deaths. We examine the bureaucracy and laziness that has broken public and law enforcement trust, fueling the opioid crisis with fentanyl and narcotics. Current guidelines, based on outdated myths, ignore neuroscience and opioid receptor science. The DEA and CDC also played a role. We need a new solution beyond temporary fixes like Narcan, addressing the root causes. Applying pattern recognition and understanding addiction can reduce deaths, depression, and addiction. Transparency and accountability in federal actions are crucial. The FDA's failure to adapt has led to a crisis; we must bypass bureaucracy, use neuroscience, and create a better future.

Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS

The opioid crisis deeply impacts the US with rising overdose deaths fueled by fentanyl. We are tasked by the FDA with finding solutions to move past this OPIOID CRISIS!, and the FDA ombudsman plays a crucial, overlooked role. Examining opioid addiction science, brain models, and receptors can lead to solutions. Current guidelines may be insufficient, requiring bypassing bureaucracy for change. Observing near-death experiences and naloxone highlights the crisis's gravity. Rethinking our approach, with the FDA ombudsman key, combining law enforcement, neuroscience, and public health can create a future free from this crisis. Adrenaline and depression linked to addiction need a holistic approach using the latest science. FDA and CDC guidelines can form a framework for a new paradigm. The crisis's future depends on asking pertinent questions and seeking innovative solutions, with the FDA ombudsman integral.